Home/Filings/4/0001104659-22-100150
4//SEC Filing

El-Dada Riad Hussein 4

Accession 0001104659-22-100150

CIK 0001567892other

Filed

Sep 13, 8:00 PM ET

Accepted

Sep 14, 9:15 PM ET

Size

6.1 KB

Accession

0001104659-22-100150

Insider Transaction Report

Form 4
Period: 2022-08-16
Transactions
  • Disposition to Issuer

    Restricted Stock Units

    2022-08-1622,53326,276 total
    Ordinary Shares (22,533 underlying)
Footnotes (1)
  • [F1](1) As previously disclosed, on August 16, 2022, Riad H. El-Dada agreed to relinquish 22,533 of the restricted stock units ("RSUs") which were previously granted to him on July 1, 2022, with relinquishment to be applied ratably across both vesting tranches of such award, to remedy ministerial errors in computation and to correct for the fact that the RSU grant may have as a technical matter exceeded the applicable annual grant maximum amount set forth in the Mallinckrodt Pharmaceuticals 2022 Stock and Incentive Plan (the "MIP"). Mallinckrodt plc ("Mallinckrodt") has agreed that, as soon as reasonably practical following January 1, 2023, Mallinckrodt will grant to Mr. El-Dada 26,277 RSUs, subject to his continued service through such date and the MIP grant value limit, which will vest ratably on each of the first two anniversaries of emergence.

Issuer

Mallinckrodt plc

CIK 0001567892

Entity typeother

Related Parties

1
  • filerCIK 0001926018

Filing Metadata

Form type
4
Filed
Sep 13, 8:00 PM ET
Accepted
Sep 14, 9:15 PM ET
Size
6.1 KB